Structure and Function of the Essential Cell Cycle Regulator Cdc34
重要细胞周期调节因子 Cdc34 的结构和功能
基本信息
- 批准号:9915951
- 负责人:
- 金额:$ 10.8万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-04-15 至 2020-05-31
- 项目状态:已结题
- 来源:
- 关键词:Active SitesAddressAffinityBindingBiochemicalBiologicalBiological AssayBiological ProcessBiologyBiophysicsC-terminalCell CycleCell Cycle ProgressionCell Cycle ProteinsCell Cycle RegulationCell divisionCell physiologyCellsCellular StructuresCellular biologyChemicalsComplexCrystallizationCullin ProteinsCyclin-Dependent Kinase InhibitorDataDevelopmentDiseaseEnsureEnzymesEukaryotic CellEventF Box DomainFDA approvedFoundationsGenerationsGenetic MaterialsGoalsHandHumanIn VitroLinkLysineMalignant NeoplasmsMethionineMitosisMolecularMultiple MyelomaN-terminalNormal CellPathway interactionsPatientsPharmaceutical PreparationsPlayPolymersPolyubiquitinPositioning AttributePost-Translational Protein ProcessingProtein EngineeringProteinsRegulationRoleSecureSignal TransductionSpecificityStructureTechniquesTestingTherapeuticTherapeutic InterventionUbiquitinUbiquitin-Conjugating EnzymesUbiquitinationWorkX-Ray CrystallographyYeastsbasecancer celldesignexperimental studyfunctional outcomesinsightintermolecular interactionlensmolecular recognitionmulticatalytic endopeptidase complexnovelprotein crosslinkreconstitutionrecruitsingle moleculetargeted treatmentubiquitin-protein ligase
项目摘要
Project Summary
The ability of the cell to control progression through the cell cycle in a regulated manner is of fundamental
importance to eukaryotic biology. Breakdown of the checkpoints controlling the cell cycle results in
catastrophic effects on normal cell function and is a defining feature of cancer cells. Cell division cycle 34
(Cdc34) is a ubiquitin (Ub) conjugating enzyme (E2) that plays an essential role in controlling progression of
the cell cycle at both the G1/S and G2/M checkpoints by ubiquitinating key cell cycle regulatory proteins and
signaling for their proteasomal destruction at defined timepoints. E2 enzymes such as Cdc34 are the
central players in the Ub conjugation cascade in which the sequential interactions and activities of three
enzymes (E1, E2, and E3) are required for ubiquitination of target proteins. This cascade is initiated by E1,
which activates and transfers Ub to tens of different E2s. The resulting E2~Ub intermediates next interact
with a repertoire of hundreds of Ub E3 ligases that catalyze Ub conjugation to target proteins by distinct
mechanisms. While in most cases the cognate E2/E3 pair responsible for regulation of a particular
biological process is unknown, the Skp, Cullin, F-box (SCF) subfamily of RING E3 ligases is well-
established to function with Cdc34 to control cell cycle progression by catalyzing the extension of Lysine 48-
linked polyubiquitin (polyUb) chains on target proteins that serve as a signal for proteasomal destruction.
Despite its fundamental importance, many key questions remain about how Cdc34 performs its functions in
the cell including: 1) how Cdc34 is recruited to E1 during formation of the Cdc34~Ub intermediate, 2) how
Cdc34~Ub is subsequently recruited to SCF, and 3) how the Cdc34/SCF complex specifically catalyzes
Lys48-linked polyUb chains that signal for proteasomal destruction of target proteins as opposed to other
types of polyUb chains. Cdc34 harbors a number of unique sequence and structural features compared to
other E2s that are crucial for its function, though the structural basis for these observations are unknown.
These features include an acidic loop insertion proximal to the active site and a large C-terminal extension,
both of which are required for Lys48-linked polyUb chain specificity and maximal enzymatic activity.
Through use of structural, biochemical/biophysical, and cell-based approaches, this proposal aims to
establish the rules governing molecular recognition in E1/Cdc34 and Cdc34/SCF interactions (Aim 1) and to
determine the structural basis by which Cdc34 and SCF function together to specifically assemble Lys48-
linked polyUb chains (Aim 2). Ub signaling is a validated target for therapeutic intervention in cancer with
FDA-approved medications targeting the proteasome currently extending the lives of multiple myeloma
patients. A molecular understanding of how E1, Cdc34, and SCF work together to control the cell cycle
resulting from the proposed studies could provide a platform for the development of novel cancer
therapeutics.
项目摘要
细胞以调节的方式控制细胞周期进程的能力是基本的
对真核生物学的重要性。控制细胞周期的检查点的崩溃导致
对正常细胞功能的灾难性影响,并且是癌细胞的定义特征。细胞分裂周期
(Cdc 34)是一种泛素(Ub)结合酶(E2),在控制肿瘤进展中起重要作用。
在G1/S和G2/M检查点通过泛素化关键细胞周期调节蛋白调节细胞周期,
在规定的时间点发出蛋白酶体破坏的信号。E2酶,如Cdc 34,
在Ub共轭级联反应中,三个分子的顺序相互作用和活动
酶(E1、E2和E3)是靶蛋白泛素化所必需的。这个级联反应是由E1启动的,
它激活并将Ub转移到数十个不同的E2上。生成的E2~Ub中间体接下来相互作用
具有数百种Ub E3连接酶的库,其通过不同的方式催化Ub与靶蛋白的缀合,
机制等虽然在大多数情况下,同源E2/E3对负责调节特定的
生物学过程是未知的,RING E3连接酶的Skp,Cullin,F-box(SCF)亚家族是良好的。
建立与Cdc 34一起发挥作用,通过催化赖氨酸48-
靶蛋白上的连接的多聚泛素(polyUb)链,作为蛋白酶体破坏的信号。
尽管Cdc 34具有根本性的重要性,但关于Cdc 34在体内如何发挥其功能的许多关键问题仍然存在。
细胞包括:1)在Cdc 34-Ub中间体形成期间,Cdc 34如何被募集到E1,2)Cdc 34-Ub中间体形成期间,
Cdc 34 ~(Ub)随后被募集到SCF中,以及3)Cdc 34/SCF复合物如何特异性地催化
Lys 48连接的polyUb链,其发出靶蛋白的蛋白酶体破坏的信号,而不是其他的
polyUb链的类型。cdc 34具有许多独特的序列和结构特征,
其他E2对它的功能至关重要,尽管这些观察结果的结构基础尚不清楚。
这些特征包括接近活性位点的酸性环插入和大的C末端延伸,
这两者都是Lys 48连接的polyUb链特异性和最大酶活性所需的。
通过使用结构、生物化学/生物物理和基于细胞的方法,该提案旨在
建立E1/Cdc 34和Cdc 34/SCF相互作用中的分子识别规则(目标1),
确定Cdc 34和SCF共同作用以特异性组装Lys 48的结构基础。
连接的polyUb链(目的2)。Ub信号传导是一个有效的癌症治疗干预靶点,
FDA批准的靶向蛋白酶体的药物目前延长了多发性骨髓瘤的生命
患者对E1、Cdc 34和SCF如何共同控制细胞周期的分子理解
从拟议的研究中产生的结果可以为新癌症的发展提供一个平台,
治疗学
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Shaun Olsen其他文献
Shaun Olsen的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Shaun Olsen', 18)}}的其他基金
Structure and Function of the Essential Cell Cycle Regulator Cdc34
重要细胞周期调节因子 Cdc34 的结构和功能
- 批准号:
10291075 - 财政年份:2019
- 资助金额:
$ 10.8万 - 项目类别:
Structure and Function of the Essential Cell Cycle Regulator Cdc34
重要细胞周期调节因子 Cdc34 的结构和功能
- 批准号:
10362572 - 财政年份:2019
- 资助金额:
$ 10.8万 - 项目类别:
Structure and Function of the Essential Cell Cycle Regulator Cdc34
重要细胞周期调节因子 Cdc34 的结构和功能
- 批准号:
10659396 - 财政年份:2019
- 资助金额:
$ 10.8万 - 项目类别:
Structural Biology of the Ubiquitin Conjugation System
泛素结合系统的结构生物学
- 批准号:
10459309 - 财政年份:2015
- 资助金额:
$ 10.8万 - 项目类别:
Structural Biology of the Ubiquitin Conjugation System
泛素结合系统的结构生物学
- 批准号:
8941933 - 财政年份:2015
- 资助金额:
$ 10.8万 - 项目类别:
Structural Biology of the Ubiquitin Conjugation System
泛素结合系统的结构生物学
- 批准号:
9146964 - 财政年份:2015
- 资助金额:
$ 10.8万 - 项目类别:
Structural Biology of the Ubiquitin Conjugation System
泛素结合系统的结构生物学
- 批准号:
10673902 - 财政年份:2015
- 资助金额:
$ 10.8万 - 项目类别:
Structural Biology of the Ubiquitin Conjugation System
泛素结合系统的结构生物学
- 批准号:
10224223 - 财政年份:2015
- 资助金额:
$ 10.8万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 10.8万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 10.8万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 10.8万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 10.8万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 10.8万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 10.8万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 10.8万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 10.8万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 10.8万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 10.8万 - 项目类别:
Research Grant